South America Neurotoxins Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Product Type (Botox, Dysport, Xenomin, and Others), Application (Therapeutic and Aesthetic), and End User (Hospitals, Specialty Clinics, Dermatology Clinics, and Others)

No. of Pages: 93    |    Report Code: BMIRE00028825    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
South America Neurotoxins Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. South America Neurotoxins Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. South America Neurotoxins Market – Key Market Dynamics

5.1 Growth Drivers
5.2 Market Opportunities
5.3 Future Trends
5.4 Impact of Drivers and Restraints

6. South America Neurotoxins Market Regional Analysis

6.1 South America Neurotoxins Market Overview
6.2 South America Neurotoxins Market Revenue 2021-2028 (US$ Million)
6.3 South America Neurotoxins Market Forecast Analysis

7. South America Neurotoxins Market Analysis – by Product Type

7.1 Botox
  • 7.1.1 Overview
  • 7.1.2 Botox: South America Neurotoxins Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Dysport
  • 7.2.1 Overview
  • 7.2.2 Dysport: South America Neurotoxins Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Xenomin
  • 7.3.1 Overview
  • 7.3.2 Xenomin: South America Neurotoxins Market – Revenue and Forecast to 2031 (US$ Million)

8. South America Neurotoxins Market Analysis – by Application

8.1 Therapeutic and Aesthetic
  • 8.1.1 Overview
  • 8.1.2 Therapeutic and Aesthetic: South America Neurotoxins Market – Revenue and Forecast to 2028 (US$ Million)

9. South America Neurotoxins Market Analysis – by End User

9.1 Hospitals
  • 9.1.1 Overview
  • 9.1.2 Therapeutic and Aesthetic: South America Neurotoxins Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Specialty Clinics
  • 9.2.1 Overview
  • 9.2.2 Therapeutic and Aesthetic: South America Neurotoxins Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Dermatology Clinics
  • 9.3.1 Overview
  • 9.3.2 Therapeutic and Aesthetic: South America Neurotoxins Market – Revenue and Forecast to 2028 (US$ Million)

10. South America Neurotoxins Market – South and Central America Analysis

10.1 South and Central America
  • 10.1.1 South America Neurotoxins Market Breakdown, by Key Country, 2024 and 2028 (%)
  • 10.1.1.1 South America Neurotoxins Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 Brazil: South America Neurotoxins Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 Brazil: South America Neurotoxins Market Breakdown, by Product Type
    • 10.1.1.1.2 Brazil: South America Neurotoxins Market Breakdown, by Application
    • 10.1.1.1.3 Brazil: South America Neurotoxins Market Breakdown, by End User
  • 10.1.1.2 Argentina: South America Neurotoxins Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Argentina: South America Neurotoxins Market Breakdown, by Product Type
    • 10.1.1.2.2 Argentina: South America Neurotoxins Market Breakdown, by Application
    • 10.1.1.2.3 Argentina: South America Neurotoxins Market Breakdown, by End User
  • 10.1.1.3 Rest of South and Central America : South America Neurotoxins Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Rest of South and Central America : South America Neurotoxins Market Breakdown, by Product Type
    • 10.1.1.3.2 Rest of South and Central America : South America Neurotoxins Market Breakdown, by Application
    • 10.1.1.3.3 Rest of South and Central America : South America Neurotoxins Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. South America Neurotoxins Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 AbbVie Inc
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Hugel Inc
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Ipsen SA
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Medytox Inc
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Merz Pharma GmbH & Co KGaA
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - S Market

  1. AbbVie Inc
  2. Hugel Inc
  3. Ipsen SA
  4. Medytox Inc
  5. Merz Pharma GmbH & Co KGaA
south-america-neurotoxins-market